Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 13, 2023, titled "Zydus receives EIR for the injectables manufacturing facility at Zydus Biotech Park, Ahmedabad".
Press Release Sep 13 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its injectables manufacturing facility at Zydus Biotech Park in Ahmedabad. The inspection, which took place in June, concluded with no observations, indicating compliance with current good manufacturing practices. This announcement serves as a disclosure in accordance with regulatory requirements for the exchange and investors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Sep 01 2023
- Press Release Aug 31 2023
- Press Release Aug 25 2023
- Press Release (Revised) Aug 24 2023
- Press Release Aug 24 2023
Later from Zydus Lifesciences
- Press Release Sep 15 2023
- Press Release Sep 19 2023
- Press Release Sep 20 2023
- Press Release Sep 29 2023
- Press Release Oct 06 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences